GT Biopharma, Inc. Quarterly Operating Lease, Liability in USD from Q1 2022 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: GT Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2022 to Q1 2024.
GT Biopharma, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $30K, a 80.9% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$30K	-$127K	-80.9%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$58M	+$57.8M	+33233%	Dec 31, 2023	10-K	2024-03-26
Q3 2023	$97K	-$217M		Sep 30, 2023	10-Q	2023-11-01
Q2 2023	$156K	-$246M		Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$157K	-$277M		Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$174K			Dec 31, 2022	10-K	2023-03-30
Q3 2022	$217M^*			Sep 30, 2022	10-Q	2022-10-31
Q2 2022	$246M^*			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$277M^*			Mar 31, 2022	10-Q	2022-05-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.